a 2545 has been researched along with flecainide in 1 studies
| Studies (a 2545) | Trials (a 2545) | Recent Studies (post-2010) (a 2545) | Studies (flecainide) | Trials (flecainide) | Recent Studies (post-2010) (flecainide) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 1,881 | 229 | 490 |
| Protein | Taxonomy | a 2545 (IC50) | flecainide (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8905 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, J; Aye, NN; Hashimoto, K; Xue, YX | 1 |
1 other study(ies) available for a 2545 and flecainide
| Article | Year |
|---|---|
Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Flecainide; Heart Rate; Mexiletine; Models, Biological; Molecular Structure; Pyrroles | 1998 |